Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19 2022-09-21 17:13
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections 2022-09-20 17:00
Apex Circuit (Thailand) Co., Ltd. Awarded at the Asia Responsible Enterprise Awards 2022 for 'Vaccine 100' under Health Promotion Category 2022-09-15 16:48
GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS 2022-09-15 10:00
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro 2022-09-13 16:08
German Chancellor Scholz, WHO Director-General Tedros, international ministers at World Health Summit 2022 2022-09-13 15:50
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio 2022-09-13 00:33
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies 2022-09-08 15:12
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action 2022-09-07 14:32
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum 2022-09-01 07:30
NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421 2022-08-31 12:24
New report highlights the technology key to fighting future pandemics 2022-08-30 04:00
AQUILAVIE LAUNCHES SAFE AND PAINLESS 'AQ LOLLIPOP' DUAL-USE COVID-19 RAPID TEST KIT FOR KIDS IN DISCOUNTED BACK-TO-SCHOOL BUNDLE 2022-08-29 14:00
Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results 2022-08-24 07:30
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head 2022-08-23 07:30
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 2022-08-22 10:05
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA 2022-08-22 08:10
Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines 2022-08-19 11:29
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17 2022-08-18 21:06
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults 2022-08-17 20:00
1 12 13 14 15 16 93